General Information of Drug Transporter (DT)
DT ID DTD0361 Transporter Info
Gene Name SLC43A2
Transporter Name L-type amino acid transporter 4
Gene ID
124935
UniProt ID
Q8N370
Post-Translational Modification of This DT
Overview of SLC43A2 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Dephosphorylation X-N-glycosylation X-Oxidation X-Phosphorylation X-Ubiquitination X: Amino Acid

Dephosphorylation

  Serine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Increasing the affinity and surface membrane localization of SLC43A2, as well as stimulating its transport activity [1]

Role of PTM

Surface Expression Modulation

Modified Residue

Serine

Modified Location

274

Experimental Material(s)

Xenopus oocytes

Experimental Method

Co-Immunoprecipitation

Detailed Description

Dephosphorylation at SLC43A2 Serine 274 have been reported to increase its affinity and surface membrane localization, as well as stimulate its transport activity.

N-glycosylation

  Asparagine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC43A2 [2]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

55

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC43A2 Asparagine 55 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC43A2 [2]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

58

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC43A2 Asparagine 58 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC43A2 [2]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

560

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC43A2 Asparagine 560 has the potential to affect its expression or activity.

Oxidation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC43A2 [3]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

295

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC43A2 Cystine 295 has the potential to affect its expression or activity.

Phosphorylation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC43A2 [4]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

160

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A2 Cystine 160 has the potential to affect its expression or activity.

  Proline

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC43A2 [5]

Role of PTM

Potential impacts

Modified Residue

Proline

Modified Location

140

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A2 Proline 140 has the potential to affect its expression or activity.

  Serine

        11 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Increasing the apparent surface expression and transport rate of SLC43A2 [1]

Role of PTM

Surface Expression Modulation

Modified Residue

Serine

Modified Location

297

Experimental Material(s)

Xenopus oocytes

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A2 Serine 297 have been reported to increase its apparent surface expression and transport rate.

  PTM Phenomenon 2

Have the potential to influence SLC43A2 [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

123

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A2 Serine 123 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC43A2 [7] , [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

249

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A2 Serine 249 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC43A2 [8] , [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

274

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A2 Serine 274 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC43A2 [5] , [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

277

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A2 Serine 277 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC43A2 [9] , [11]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

278

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A2 Serine 278 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC43A2 [8] , [12]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

281

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A2 Serine 281 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC43A2 [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

396

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A2 Serine 396 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence SLC43A2 [13]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

453

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A2 Serine 453 has the potential to affect its expression or activity.

  PTM Phenomenon 10

Have the potential to influence SLC43A2 [14] , [15]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

562

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A2 Serine 562 has the potential to affect its expression or activity.

  PTM Phenomenon 11

Have the potential to influence SLC43A2 [15] , [16]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

563

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A2 Serine 563 has the potential to affect its expression or activity.

  Threonine

          8 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC43A2 [17] , [18]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

4

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A2 Threonine 4 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC43A2 [17] , [18]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

7

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A2 Threonine 7 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC43A2 [18]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

18

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A2 Threonine 18 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC43A2 [8] , [19]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

267

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A2 Threonine 267 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC43A2 [20]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

268

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A2 Threonine 268 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC43A2 [6] , [21]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

298

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A2 Threonine 298 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC43A2 [13]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

441

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A2 Threonine 441 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC43A2 [13]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

458

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A2 Threonine 458 has the potential to affect its expression or activity.

Ubiquitination

  Glutamine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC43A2 [4] , [22]

Role of PTM

Potential impacts

Modified Residue

Glutamine

Modified Location

265

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC43A2 Glutamine 265 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC43A2 [4] , [22]

Role of PTM

Potential impacts

Modified Residue

Glutamine

Modified Location

406

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC43A2 Glutamine 406 has the potential to affect its expression or activity.

  Isoleucine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC43A2 [22]

Role of PTM

Potential impacts

Modified Residue

Isoleucine

Modified Location

421

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC43A2 Isoleucine 421 has the potential to affect its expression or activity.

  Leucine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC43A2 [23] , [24]

Role of PTM

Potential impacts

Modified Residue

Leucine

Modified Location

146

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC43A2 Leucine 146 has the potential to affect its expression or activity.

  Lysine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC43A2 [24]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

260

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC43A2 Lysine 260 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC43A2 [25]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

283

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC43A2 Lysine 283 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC43A2 [25]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

402

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC43A2 Lysine 402 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC43A2 [25]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

558

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC43A2 Lysine 558 has the potential to affect its expression or activity.

  Serine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC43A2 [24]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

123

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC43A2 Serine 123 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC43A2 [22]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

525

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC43A2 Serine 525 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC43A2 [22]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

562

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC43A2 Serine 562 has the potential to affect its expression or activity.

  Tryptophan

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC43A2 [26]

Role of PTM

Potential impacts

Modified Residue

Tryptophan

Modified Location

250

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC43A2 Tryptophan 250 has the potential to affect its expression or activity.

  Valine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC43A2 [22]

Role of PTM

Potential impacts

Modified Residue

Valine

Modified Location

369

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC43A2 Valine 369 has the potential to affect its expression or activity.
References
1 Anticipation of food intake induces phosphorylation switch to regulate basolateral amino acid transporter LAT4 (SLC43A2) function. J Physiol. 2019 Jan;597(2):521-542.
2 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: LAT4_HUMAN)
3 A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
4 Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling. Mol Cell. 2020 Mar 5;77(5):1124-1142.e10.
5 Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2. Mol Cell. 2020 Dec 17;80(6):1104-1122.e9.
6 Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
7 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
8 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
9 UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
10 Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.
11 A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
12 Quantitative phosphoproteomics unveils temporal dynamics of thrombin signaling in human endothelial cells. Blood. 2014 Mar 20;123(12):e22-36.
13 Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins. Proteomics. 2015 Jan;15(2-3):508-519.
14 Protein kinase C-alpha interaction with F0F1-ATPase promotes F0F1-ATPase activity and reduces energy deficits in injured renal cells. J Biol Chem. 2015 Mar 13;290(11):7054-66.
15 Integrated Proteomics Reveals Apoptosis-related Mechanisms Associated with Placental Malaria. Mol Cell Proteomics. 2019 Feb;18(2):182-199.
16 Improved Method for Determining Absolute Phosphorylation Stoichiometry Using Bayesian Statistics and Isobaric Labeling. J Proteome Res. 2017 Nov 3;16(11):4217-4226.
17 Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics. Mol Cell Proteomics. 2013 Dec;12(12):3851-73.
18 An Augmented Multiple-Protease-Based Human Phosphopeptide Atlas. Cell Rep. 2015 Jun 23;11(11):1834-43.
19 Comprehensive quantitative comparison of the membrane proteome, phosphoproteome, and sialiome of human embryonic and neural stem cells. Mol Cell Proteomics. 2014 Jan;13(1):311-28.
20 Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
21 Modulation of Cl- signaling and ion transport by recruitment of kinases and phosphatases mediated by the regulatory protein IRBIT. Sci Signal. 2018 Oct 30;11(554):eaat5018.
22 Global identification of modular cullin-RING ligase substrates. Cell. 2011 Oct 14;147(2):459-74.
23 Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. Nature. 2021 Jun;594(7862):246-252.
24 UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.
25 Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.
26 Ubiquitin ligase substrate identification through quantitative proteomics at both the protein and peptide levels. J Biol Chem. 2011 Dec 2;286(48):41530-41538.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.